Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816

Phase 1 Completed 36 enrolled Hanmi Pharmaceutical Company Limited

RandomizedCrossoverOpen-labelTreatment

Summary

The investigators investigate the potential pharmacokinetic drug-drug interaction between HGP0918 and HGP0816 in healthy adult subjects who receive HGP0918 alone, HGP0816 alone, and both together in a 3 period repeatedly

Timeline

Start: 2015-07
Primary completion: 2015-08
Completion: 2015-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HGP0816	Unknown	—	—
Subject	HGP0918	Unknown	—	—

Indications

No indication recorded.